nirmatrelvir

The New England Journal of Medicine (NEJM) is perhaps the world’s most prestigious medical journal, so it is both interesting and informative to see its editors’ compilation of what they consider its “notable articles” of the previous year. T

If there is a single lesson to be learned from three years of the pandemic, it's that if you're going to try to treat Covid with a drug, it had better be a direct-acting antiviral drug. (1)

The White House just announced a "test to treat" program that is an excellent, but not perfect, way of dealing with future COVID infections.

Following the FDA's granting of Emergency Use Authorization to Merck's molnupiravir and Pfizer's Paxlovid, the only two approved direct-acting antiviral drugs; we now have two badly needed tools to deal with COVID, especially since it is